Pillstats
Rx only · Kit

Adalimumab

Brands: Humira

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)327361
US makers3 labelers
Packages23
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1276.92$2553.84$3830.77$5107.69Mar 2025Mar 2026Jul 2026
$4344.854
Latest avg · Jul 22, 2026
-2%
Since Mar 19, 2025
3
Active US suppliers
96%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

61K121K182K243K2025 Q12025 Q22025 Q32025 Q42026 Q1
135K
Rx · 2026 Q1
329K
Units dispensed
-36%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
AbbVie Inc.unknown17SUPPLYING
Cordavis Limitedunknown5SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.